CellSeed Inc. (7776.T)
JPY 408.0
(-7.69%)
JPY 408.0
(-7.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -846.53 Million JPY | -11.43% |
| 2022 | -759.68 Million JPY | 16.78% |
| 2021 | -912.87 Million JPY | -16.46% |
| 2020 | -783.86 Million JPY | -0.19% |
| 2019 | -782.39 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -244.79 Million JPY | -6.59% |
| 2024 Q1 | -229.66 Million JPY | 12.35% |
| 2023 Q2 | -179.96 Million JPY | 2.19% |
| 2023 Q4 | -262.02 Million JPY | -18.8% |
| 2023 FY | -846.53 Million JPY | -11.43% |
| 2023 Q1 | -183.99 Million JPY | 0.71% |
| 2023 Q3 | -220.55 Million JPY | -22.55% |
| 2022 Q3 | -217.25 Million JPY | 0.0% |
| 2022 FY | -759.68 Million JPY | 16.78% |
| 2022 Q4 | -185.3 Million JPY | 14.71% |
| 2021 FY | -912.87 Million JPY | -16.46% |
| 2020 FY | -783.86 Million JPY | -0.19% |
| 2019 FY | -782.39 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 320.452% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -60.659% |
| GNI Group Ltd. | 8.09 Billion JPY | 110.459% |
| Linical Co., Ltd. | 338.26 Million JPY | 350.257% |
| Trans Genic Inc. | 4.08 Million JPY | 20822.987% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 41.129% |
| Soiken Holdings Inc. | -662.2 Million JPY | -27.836% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 712.742% |
| AnGes, Inc. | -7.43 Billion JPY | 88.618% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 34.282% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 88.231% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 553.434% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -8.53% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 26.573% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 29.981% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -4.2% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -161.549% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 30.613% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 40.472% |
| PeptiDream Inc. | 3.03 Billion JPY | 127.885% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 56.331% |
| Ribomic Inc. | -1.02 Billion JPY | 17.35% |
| SanBio Company Limited | -2.64 Billion JPY | 67.983% |
| Healios K.K. | -3.82 Billion JPY | 77.857% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 27.528% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 43.17% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 40.777% |
| StemRIM | -2.02 Billion JPY | 58.134% |
| CellSource Co., Ltd. | 923.14 Million JPY | 191.701% |
| FunPep Company Limited | -933.41 Million JPY | 9.308% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 0.892% |
| Stella Pharma Corporation | -763.74 Million JPY | -10.839% |
| TMS Co., Ltd. | -960.04 Million JPY | 11.823% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 25.086% |
| Cuorips Inc. | -632.18 Million JPY | -33.906% |
| K Pharma,Inc. | 260.33 Million JPY | 425.177% |
| Takara Bio Inc. | 1.48 Billion JPY | 157.198% |
| ReproCELL Incorporated | -31.41 Million JPY | -2594.681% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 3309.243% |
| StemCell Institute Inc. | 310.98 Million JPY | 372.214% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 691.283% |